Market data
Biotechnology Pharmaceuticals
Explore verified biotechnology pharmaceuticals statistics and market research reports with sourced data and trend analysis.
Latest update:


Microalgae Industry Statistics
Global aquaculture hit 82.1 million tonnes in 2018—and microalgae-based feeds are a key demand driver. Explore the microalgae industry stats behind it.

Biopharmaceutical Industry Statistics
Phase III trials cost about $255M per drug on average in 2023—see what drives the industry’s investment pipeline.

Opiod Statistics
In 2021, synthetic opioids (mostly fentanyl) were in 88% of 71,238 opioid-involved deaths—see how the crisis is shifting.

Turkey Pharmaceutical Industry Statistics
Turkey’s pharma exports reached $1.82B in 2023 (+22%). Generic drugs were $1.1B—explore what’s driving the surge.

Biopharma Industry Statistics
Gene therapy is forecast to grow to $250.0B by 2023—plus 17% of biopharma trials are adding decentralization. See the numbers.

Bio Industry Statistics
Bioeconomy market size reached $307.3B in 2022—while biopharma funding fell 11% YoY in 2023. Explore the signals shaping bio industry investment.

Hydrocodone Statistics
10.1 million U.S. residents aged 12+ misused prescription pain relievers in the past year—hydrocodone is among the opioids involved.

Bio Healthcare Industry Statistics
Oncology trials drove 38% of biotech’s 2023 studies—explore the Bio Healthcare Industry stats behind what’s moving fastest.

Vaccine Industry Statistics
13.5B+ COVID-19 vaccine doses were administered worldwide by end-2022—yet 3.2B children missed at least one routine dose. Explore the gap.

Insulin Statistics
WHO estimates 422 million adults worldwide lived with diabetes in 2014—discover why insulin can be essential for type 1 care.

Weight Loss Drugs Food Industry Statistics
U.S. obesity drug prescriptions surged in 2023—see how that demand is reshaping what Americans buy and how food rules respond.

Life Sciences Industry Statistics
Global patent filings hit 250,000 in 2023—discover what this surge signals for innovation, funding, and therapies.

Korea Bio Industry Statistics
Biopharmaceutical exports hit USD 8.7B in 2023 (61% of total)—see what’s driving Korea’s biotech trade momentum and pipeline.

Biotechnology Healthcare Industry Statistics
U.S. biotech VC funding hit USD 35B in 2023—down 30% from the 2022 peak. Explore what’s fueling the next approvals.

Korean Pharmaceutical Industry Statistics
South Korea’s pharma exports reached $12.8 billion in 2023—see how biotech, generics, and key destinations power the figures.

Indian Pharma Industry Statistics
Exports grew 8.5% YoY to $25.39B in FY23—India’s pharma is scaling fast. Explore jobs, R&D, and capacity signals behind the surge.

Us Biotechnology Industry Statistics
US biotechs generated $50B in mRNA vaccine sales in 2022—see the growth metrics, jobs, and funding behind the surge.

Genomics Industry Statistics

Bioinformatics Statistics
With genomics data set to hit 2,800 petabytes by 2030, the page connects research and operational reality to why bioinformatics statistics matter, from 5.5 billion annual U.S. clinical data points from genomic tests to 52% of labs already running cloud workloads. You also get the operational tension behind pipeline design and reuse, including 43% of organizations struggling with cross system integration and workflow practices like Nextflow style reproducible DAG execution that increasingly separate results that can be trusted from those that cannot.

Biotech Pharma Industry Statistics
Biotech and biopharma are accelerating fast as the global biotechnology market is projected to hit $1.26 trillion by 2030 and CDMO growth is forecast at 4.1% annually through 2032. At the same time, investors put $91.0 billion into biotech in 2021 and the FDA keeps tilting approvals toward biologics, making these supply chain and regulatory signals impossible to ignore for anyone tracking what is next in drug development.